Company / Cash per Share
Tyra Biosciences, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.61
FY2024
5-year range
$1.36 / $21.93
FY2020-FY2024
Trend
+18.3%
vs FY2023
Sector context
#120 of 205
Health Care
What the data says
At $1.61, Tyra Biosciences, Inc.'s cash per share ranks #120 of 205 in the Health Care sector. Cash per Share returned to growth in FY2024 after 2 years of decline, reaching $1.61.
Based on SEC 10-K filings.
1.61 in FY2024 with a 3-year CAGR of -58.1%.
Declined from $6.00 to $1.61 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -58.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 205 in Health CareTop 59% of 205This company $1.61 Sector average $72.93
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 18.3% year-over-year.
- Ranks #120 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.61 | +18.3% |
| FY2023 | $1.36 | -77.4% |
| FY2022 | $6.00 | -72.6% |
| FY2021 | $21.93 | +122.1% |
| FY2020 | $9.87 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026